Related Experiment Video
Updated: Aug 8, 2025

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
Post-COVID Mucormycosis Involving Mandible: A Rare Phenomenon
Manish Raghani1, Hafiz Md Nasimuddin Ansari1, Abdul Hafeez A1
1Oral and Maxillofacial Surgery, All India Institute of Medical Sciences, Raipur, Raipur, IND.
Abstract:
Mucormycosis is a fungal disease involving predominantly the paranasal sinuses and further spreading to the orbit and cerebral regions. It does rarely affect the pulmonary region and gastrointestinal regions. This disease is seen more in a very serious state, where the tissues undergo necrosis and cause huge morbidity and, in some cases, end up being fatal. The disease was common in individuals with an immune-compromised state, thus more commonly presenting in individuals with uncontrolled diabetes. The disease is usually acquired through coming into contact with spores of the fungus Mucormycetes through the nose, and the fungi invade the paranasal regions, colonize, and spread locally with angio-invasion and relying on host ferritin for survival, thereby causing tissue necrosis. The incidence of mucormycosis had increased considerably post-COVID-19 due to host immune factors. This fungus commonly spreads from paranasal regions to the cranial direction through orbit. The spread is rapid, thus needing early medical and surgical intervention. The spread of infection from the paranasal regions to the caudally placed mandible is very rarely seen. In this paper, we present three cases of mucormycosis spreading caudally and involving the mandibular regions.
Insights
Mucormycosis, a serious fungal infection, typically affects sinuses and can spread to the brain. This study highlights rare cases where the infection spread downwards to involve the mandible.
Area of Science:
- Mycology
- Infectious Diseases
- Otolaryngology
Background:
- Mucormycosis is a severe fungal infection primarily affecting the paranasal sinuses, orbit, and brain.
- It is often seen in immunocompromised individuals, particularly those with uncontrolled diabetes.
- Post-COVID-19, an increase in mucormycosis incidence has been observed due to altered host immune factors.

